SYNERON MED Stock Price, News & Analysis
ELOS
Company Description
SYNERON MED (Nasdaq: ELOS) is a publicly traded company.
ELOS stock has gained 45.7% over the past year.
This page provides a comprehensive overview of ELOS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+45.7%
Performance 1 year
$0.0
SYNERON MED (ELOS) stock. Over the past 12 months, the stock has gained 45.7%.
Latest News
SYNERON MED has 1 recent news article. Key topics include clinical trial, fda approval. View all ELOS news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months